<DOC>
	<DOCNO>NCT03023514</DOCNO>
	<brief_summary>Alpha-Lipoic Acid ( ALA ) natural molecule make significant contribution success embryo implantation phase , exerts , directly indirectly , immunomodulatory activity . ALA ability regenerate antioxidant molecule facilitate embryo implantation , stimulate production local mediator useful implantation . This study prospective clinical trial aim evaluate reproductive outcome Italian couple follow oocyte donation fresh cycle receive per os tablet lipoic acid . Indeed , control group standard treatment ( vaginal progesterone ) , whereas study group , addition , receive ALA ( 300 mg , 2 time per day ) oral route , day donor oocyte pick pregnancy test . If childbearing occur , treatment continue 8th week pregnancy . Primary outcome study implantation rate positive hCG rate , clinical pregnancy rate , miscarriage rate live-birth rate secondary outcome .</brief_summary>
	<brief_title>Lipoic Acid Supplementation IVF</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Donors : Proof fertility ; ⩽32 year old BMI &lt; 30 kg/m2 Regular menstrual cycle 2533 day Two normal ovary base transvaginal scan finding . Recipients : Women infertility problem ⩽50 year old , BMI &lt; 34 kg/m2 Donors : Polycystic ovary Endometriosis Gynaecological medical disorder . Recipients : Endocrinologic problem Medication chronic illness Azoospermic partner require TESE Sperm donation cycle</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Oocyte donation</keyword>
	<keyword>IVF</keyword>
	<keyword>Lipoic acid</keyword>
	<keyword>Implantation rate</keyword>
	<keyword>Endometrial receptivity</keyword>
</DOC>